Protocol Name: Observational Study Protocol – Fabry Disease Registry
Sponsor: Sanofi-Aventis
Indication: Fabry Disease
Principal Investigator: Ankit Mehta, MD
Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204